Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials Post author: Post published:December 5, 2023 Post category:uncategorized The safety, efficacy, and immunogenicity of a mRNA-based vaccine. You Might Also Like HHCM awards $566K to advance psychedelic end-of-life care research January 27, 2026 Study shows link between gum disease and white matter hyperintensities October 23, 2025 Healthy habits linked to younger brain age September 25, 2025